Human amniotic epithelial stem cell therapy (Shanghai East Hospital)

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameHuman amniotic epithelial stem cell therapy (Shanghai East Hospital)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsGraft vs Host DiseaseParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesShanghai Oriental Hospital
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Icell Biotechnology Co., Ltd, Shanghai, ChinaShanghai Oriental Hospital
Inactive CompaniesN/A
Active IndicationsGraft vs Host DiseaseParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A